Literature DB >> 14622547

[Primary cardiac lymphoma: diagnosis by transjugular biopsy].

Angela Flox Camacho1, Felipe Hernández Hernández, Rafael Salguero Bodes, Ignacio Sánchez Pérez, Amparo Carbonell Porras, Juan Tascón Pérez.   

Abstract

Primary cardiac lymphoma, defined as a non-Hodgkin's lymphoma involving only the heart and pericardium, is an extremely rare malignancy. It should be suspected in patients with a heart mass and heart failure, unexplained refractory pericardial effusion or rhythm disturbances. Transvenous intracardiac tumor biopsy under fluoroscopic or transesophageal echocardiographic guidance, is a minimally invasive technique which makes definite diagnosis possible. We describe a patient in whom primary cardiac lymphoma was diagnosed by this technique. He also underwent percutaneous balloon pericardiotomy because of severe refractory pericardial effusion. Seven months after diagnosis and treatment with standard chemotherapy, the patient remained free of disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622547     DOI: 10.1016/s0300-8932(03)77026-2

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  3 in total

1.  Broadening the scope of thoracic oncological intervention: a novel minimally invasive method for the diagnosis of primary cardiac lymphoma.

Authors:  Karen Sayal; Tariq Ali; Angela Tasker; Nicholas Carroll
Journal:  BMJ Case Rep       Date:  2015-05-14

2.  Successful treatment of a large primary cardiac lymphoma by surgical resection combined with chemotherapy: report of a case.

Authors:  Takuji Kawamura; Taichi Sakaguchi; Hiroyuki Nishi; Shigeru Miyagawa; Yasushi Yoshikawa; Takashi Yamauchi; Satsuki Fukushima; Shunsuke Saito; Yoshiki Sawa
Journal:  Surg Today       Date:  2012-08-14       Impact factor: 2.549

3.  Primary Cardiac Diffuse Large B-cell Lymphoma Promptly and Safely Diagnosed with Pericardial Effusion Cytology.

Authors:  Haruna Fukuzaki; Kentaro Fukuda; Akihiro Sato; Masayuki Shiozaki; Naozumi Kubota; Hiroshi Tamura; Kenji Inoue; Yasumasa Fujiwara; Masataka Sumiyoshi
Journal:  Intern Med       Date:  2020-04-30       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.